Mycoplasma contamination affects an estimated 62 percent of cell cultures, challenging laboratories worldwide. These invisible contaminants compromise cell health, alter experimental outcomes, and can lead to substantial data loss, costly disruptions, and regulatory hurdles. For biopharmaceutical and research institutions alike, early detection is essential for maintaining the integrity of scientific endeavors.

This white paper examines strategies for managing mycoplasma contamination in cell culture research, emphasizing the importance of selecting an effective detection method. It provides insights into evaluating detection options based on cost, speed, and reliability while addressing how mycoplasma’s unique characteristics allow it to evade traditional methods. Discover why regular, accurate screening is essential for maintaining research integrity and achieving reliable results.
Download the full white paper to learn:
- The widespread threat of mycoplasma contamination in cell cultures
- Key challenges posed by undetected mycoplasma
- Comparative insights into leading detection methods, including qPCR technology
- Actionable steps to enhance prevention and maintain culture integrity